Quantifying the Effects of Prior Acetyl-Salicylic Acid on Sepsis-Related Deaths: An Individual Patient Data Meta-Analysis Using Propensity Matching*
James Trauer,Stephen Muhi,Emma S. McBryde,Shmeylan A. Al Harbi,Yaseen M. Arabi,Andrew J. Boyle,Rodrigo Cartin-Ceba,Wei Chen,Yung-Tai Chen,Marco Falcone,Ognjen Gajic,Jack Godsell,Michelle Ng Gong,Daryl Kor,Wolfgang Lösche,Daniel F. McAuley,Hollis R. O’Neal,Michael Osthoff,Gordon P. Otto,Maik Sossdorf,Min-Juei Tsai,Juan C. Valerio-Rojas,Tom van der Poll,Francesco Violi,Lorraine Ware,Andreas F. Widmer,Maryse A. Wiewel,Johannes Winning,Damon P. Eisen,Muhi, Stephen,Lösche, Wolfgang,Ware, Lorraine,O’Neal, Hollis R. Jr,Cartin-Ceba, Rodrigo,Chen, Wei,Trauer, James,McAuley, Daniel F.,Violi, Francesco,McBryde, Emma S.,Falcone, Marco,Chen, Yung-Tai,Sossdorf, Maik,Kor, Daryl,Godsell, Jack,van der Poll, Tom,Otto, Gordon P.,Tsai, Min-Juei,Osthoff, Michael,Boyle, Andrew J.,Winning, Johannes,Valerio-Rojas, Juan C.,Wiewel, Maryse A.,Widmer, Andreas F.,Arabi, Yaseen M.,Al Harbi, Shmeylan A.,Eisen, Damon P.,Gong, Michelle Ng,Gajic, Ognjen
DOI: https://doi.org/10.1097/CCM.0000000000002654
IF: 8.8
2019-10-03
Critical Care Medicine
Abstract:Objective: Objective:The primary objective was to conduct a meta-analysis on published observational cohort data describing the association between acetyl-salicylic acid (aspirin) use prior to the onset of sepsis and mortality in hospitalized patients.
Study Selection: Study Selection:Studies that reported mortality in patients on aspirin with sepsis with a comparison group of patients with sepsis not on prior aspirin therapy were included.
Data Sources: Data Sources:Fifteen studies described hospital-based cohorts (n = 17,065), whereas one was a large insurance-based database (n = 683,421). Individual-level patient data were incorporated from all selected studies.
Data Extraction: Data Extraction:Propensity analyses with 1:1 propensity score matching at the study level were performed, using the most consistently available covariates judged to be associated with aspirin. Meta-analyses were performed to estimate the pooled average treatment effect of aspirin on sepsis-related mortality.
Data Synthesis: Data Synthesis:Use of aspirin was associated with a 7% (95% CI, 2–12%; p = 0.005) reduction in the risk of death as shown by meta-analysis with considerable statistical heterogeneity (I2 = 61.6%).
Conclusions: Conclusions:These results are consistent with effects ranging from a 2% to 12% reduction in mortality risk in patients taking aspirin prior to sepsis onset. This association anticipates results of definitive studies of the use of low-dose aspirin as a strategy for reduction of deaths in patients with sepsis.
critical care medicine